AKUMS DRUGS & PHARMACEUTICALS
Back to Income Statement
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹4,118 Cr | ₹4,178 Cr | ₹3,655 Cr | ₹3,672 Cr | ₹2,723 Cr |
What is the latest Revenue of AKUMS DRUGS & PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹4,118 Cr |
| Mar2024 | ₹4,178 Cr |
| Mar2023 | ₹3,655 Cr |
| Mar2022 | ₹3,672 Cr |
| Mar2021 | ₹2,723 Cr |
How is Revenue of AKUMS DRUGS & PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,118 Cr | -1.44 | |
| Mar2024 | ₹4,178 Cr | 14.32 | |
| Mar2023 | ₹3,655 Cr | -0.46 | |
| Mar2022 | ₹3,672 Cr | 34.87 | |
| Mar2021 | ₹2,723 Cr | - | |
Compare Revenue of peers of AKUMS DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AKUMS DRUGS & PHARMACEUTICALS | ₹8,635.0 Cr | 1.7% | -1.5% | -2.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,938.0 Cr | -0.6% | -3.7% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 2.8% | 0.7% | -0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,385.0 Cr | 2.4% | 2.1% | 40.8% | Stock Analytics | |
| CIPLA | ₹111,220.0 Cr | 0.1% | 2.2% | -5.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,899.0 Cr | 0.5% | -1.9% | 2.2% | Stock Analytics | |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AKUMS DRUGS & PHARMACEUTICALS | 1.7% |
-1.5% |
-2.7% |
| SENSEX | -1% |
-5% |
-9.2% |
You may also like the below Video Courses